The autophagy-related Beclin-۱ expression as a potentialdiagnostic biomarker for COVID-۱۹.

سال انتشار: 1401
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 91

نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

MEDISM23_080

تاریخ نمایه سازی: 16 مهر 1401

چکیده مقاله:

Background and Aim : SARS-CoV-۲ is a novel beta-coronavirus that causes the current COVID-۱۹ pandemic. Previous studies have shown that coronaviruses use various cellular mechanismssuch as autophagy to increase their replication. Autophagy is responsible for the selective removalof dysfunctional organelles, intracellular pathogens, and misplaced proteins, as well as theregulation of the immune response. Then autophagy is closely related to the host inflammatoryresponse. Autophagy has a protective role in reducing the excessive release of cytokines inARDS[۱-۳]. Analysis of transcriptome data in the lung cell line infected with SARS-CoV-۲ hasshown a change in the autophagy response[۴]. SARS-CoV ORF-۹b protein could induceautophagy and activate NF-κB[۵]. Induction of autophagy also seems to be one of the primaryfunctions of cGAS-STING. The cGAS-STING pathway induces autophagy directly via Beclin-۱or LC۳-dependent pathways[۱]. Inhibition of autophagy in the first stage of COVID-۱۹ may leadto the regulation of the interferon antiviral response and inhibition of viral replication. Activationof autophagy in the late stage of the disease could lead to reduce inflammation and balance theimmune response. For these reasons, autophagy-related therapeutic maybe useful for COVID-۱۹[۶]. The aim of this study is to evaluate the expression level of autophagy-related Beclin-۱ inCOVID-۱۹ patients compared to healthy controls.Methods : In this case-control study, blood samples were taken from ۱۵ patients with COVID-۱۹and also ۱۵ healthy controls. After total RNA extraction and cDNA synthesis, we used Real-timePCR to evaluate the expression level of Beclin-۱. The data were analyzed by ۲-ΔΔCt method. ROCcurve analysis was also performed to evaluate diagnostic accuracy.Results : The result shows that expression level of Beclin-۱ in COVID-۱۹ patients was upregulatedcompared to the healthy controls (Fold change=۱, p value=۰.۰۳). The area under thecurve (AUC) of Beclin-۱ for diagnosing COVID-۱۹ compared to controls was ۰.۸۸ (۹۵% CI= ۰.۷۵to ۱, p value=۰.۰۰) and the optimal cut-off value was calculated to be >۰.۰۰۰۹ (Sensitivity ۱۰۰%;Specificity ۷۳.۳۳%).Conclusion : According to our results, blood Beclin-۱ expression levels may serve as a potentialbiomarker for COVID-۱۹ diagnosis.

کلیدواژه ها:

نویسندگان

Shahrzad Shoraka

Department of Microbiology and Microbial Biotechnology, Faculty of Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, Iran

Seyed Reza Mohebbi

Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Seyed Masoud Hosseini

Department of Microbiology and Microbial Biotechnology, Faculty of Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, Iran

Mohammad Reza Zali

Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Arabi str., Yaman Ave., Velenjak, Tehran, Iran